Gross-Gerau, Germany

Mike Brandner

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Poxel S.a.s.. Active years: 2013.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mike Brandner: Innovator in Chemical Production

Introduction

Mike Brandner is a notable inventor based in Gross-Gerau, Germany. He has made significant contributions to the field of chemical production, particularly through his innovative methods and processes. His work has led to the development of valuable compounds that have applications in various industries.

Latest Patents

Mike Brandner holds a patent for a method for the production of 3,6-dihydro-L, 3, 5-triazine derivatives from metformin and paraldehyde derivatives. This patent outlines a process for the preparation of compounds of a specific formula, showcasing his expertise in chemical synthesis and innovation. He has 1 patent to his name, reflecting his commitment to advancing chemical methodologies.

Career Highlights

Throughout his career, Mike has been associated with Poxel S.a.s., a company known for its focus on innovative pharmaceutical solutions. His role at Poxel has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

One of his notable collaborators is Matthias Helmreich. Together, they have worked on various projects that aim to enhance the efficiency and effectiveness of chemical production processes.

Conclusion

Mike Brandner's contributions to the field of chemical production are noteworthy, and his innovative methods continue to influence the industry. His patent and collaborations highlight his dedication to advancing scientific knowledge and practical applications in chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…